BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:65@canceropole-clara.com
DTSTART;TZID=Europe/Paris:20250211T000000
DTEND;TZID=Europe/Paris:20250212T000000
DTSTAMP:20250204T150436Z
URL:https://www.canceropole-clara.com/events/eacr-boehringer-ingelheim-reg
 ulation-of-the-map-kinase-pathway/
SUMMARY:EACR/Boehringer Ingelheim: Regulation of the MAP Kinase Pathway
DESCRIPTION:Virtual Event - February 11 &amp\; 12\, 2025\n\nThe Mitogen Act
 ivated Protein Kinase (MAPK) pathway is one of the most commonly mutated s
 ignalling pathways in human cancers. While a range of small molecule inhib
 itors have been developed to inhibit the upstream and downstream effectors
  of this pathway\, resistance remains a significant challenge.\n\nTarget a
 udience\n\nThose in academia and industry that are interested in the role 
 of the MAPK pathway in the context of genetically targeted and immune-base
 d anticancer therapies. The meeting will focus on both the mechanistic as
 pects of gene regulation\, target validation\, and drug development\, as w
 ell as emerging clinical and translational opportunities.\n\nTopics to be
  covered:\n\n 	Regulation of MAPK signalling\n 	Drug resistance mechanisms
 \n 	Rational combination therapies\n 	Cross-resistance to immune modulator
 s\n\nDeadline for abstract submission: December 16\, 2024\n\nDeadline for
  registration: January 24\, 2025\n\nMore information &gt\;&gt\;
CATEGORIES:Autres événements
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Paris
X-LIC-LOCATION:Europe/Paris
BEGIN:STANDARD
DTSTART:20241027T020000
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
END:STANDARD
END:VTIMEZONE
END:VCALENDAR